SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-21-233921
Filing Date
2021-08-03
Accepted
2021-08-03 06:04:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d109461d8a12b.htm 8-A12B 12868
  Complete submission text file 0001193125-21-233921.txt   13869
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-40703 | Film No.: 211137809
SIC: 2836 Biological Products, (No Diagnostic Substances)